Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Stroke. 2014 Feb 18;45(4):1012–1017. doi: 10.1161/STROKEAHA.113.004166

Table 1.

Baseline characteristics of participants.

Any Retinopathy
(n=50)
No
Retinopathy
(n=722)
p-value AV Nicking
(n=108)
No AV nicking
(n=709)
p-value
Age, y 60.9 (3.9) 61.5 (4.4) 0.39 62.2 (4.0) 61.3 (4.4) 0.04
Men (%) 48.0 39.4 0.23 44.4 39.8 0.36
Black Race (%) 64.0 45.7 0.01 57.4 46.5 0.04
Study Center
Jackson, MS (%)
60.0 40.4 0.007 53.7 41.2 0.01
Hypertension (%) 64.0 41.0 0.001 50.9 40.7 0.05
Cumulative SBP,
mm Hg
130.9 (18.3) 123.1 (16.5) 0.002 127.3 (16.3) 123.2 (16.6) 0.02
Diabetes (%) 36.0 11.4 <0.001 13.3 13.1 0.96
Blood Glucose,
mg/dl
142.9 (75.3) 106.4 (31.5) 0.001 106.7 (24.5) 109.1 (38.3) 0.39
Ever Smoked (%) 54.0 53.3 0.92 57.1 53.0 0.43
Pack Years 7.9 (16.7) 13.7 (25.2) 0.03 13.1 (23.1) 13.3 (24.7) 0.95
Total Cholesterol,
mg/dl
212.8 (37.0) 209.1 (37.2) 0.50 205.2 (37.2) 209.4 (37.3) 0.28s
HDL Cholesterol,
mg/dl
51.5 (17.8) 55.9 (18.9) 0.11 56.1 (18.0) 55.5 (18.8) 0.76
BMI 28.1 (4.2) 27.1 (4.7) 0.14 27.6 (4.3) 27.1 (4.7) 0.25
CHD (%) 4.2 3.5 0.82 3.7 3.3 0.82

Data are mean (SD) for continuous data and % for categorical data.

SBP indicates systolic blood pressure, HDL, high-density lipoprotein; LDL, low-density lipoprotein; BMI, body mass index; CHD, Coronary Heart Disease.